Source: The Korea Bizwire

InDevR: InDevR Launches Highly Multiplexed Kit for Rapid Pneumococcal Vaccine Characterization

BOULDER, Colo., May 10 (Korea Bizwire) - InDevR, Inc., a life science tools company providing powerful analytical technologies to support the development and production of vaccines and biotherapeutics, announced the commercial availability of its VaxArray® Pneumococcal Assay Kit for rapid and accurate assessment of pneumococcal vaccines at all stages of manufacturing, including multivalent drug product. This launch [...]The post InDevR Launches Highly Multiplexed Kit for Rapid Pneumococcal Vaccine Characterization appeared first on Be Korea-savvy.

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Kathy Rowlen's photo - Co-Founder & CEO of InDevR

Co-Founder & CEO

Kathy Rowlen

CEO Approval Rating

82/100

Read more